全文获取类型
收费全文 | 654篇 |
免费 | 66篇 |
国内免费 | 8篇 |
专业分类
儿科学 | 3篇 |
基础医学 | 110篇 |
口腔科学 | 90篇 |
临床医学 | 10篇 |
内科学 | 81篇 |
神经病学 | 2篇 |
特种医学 | 5篇 |
外科学 | 291篇 |
综合类 | 51篇 |
预防医学 | 6篇 |
眼科学 | 1篇 |
药学 | 44篇 |
中国医学 | 15篇 |
肿瘤学 | 19篇 |
出版年
2024年 | 1篇 |
2023年 | 12篇 |
2022年 | 6篇 |
2021年 | 16篇 |
2020年 | 9篇 |
2019年 | 11篇 |
2018年 | 16篇 |
2017年 | 11篇 |
2016年 | 19篇 |
2015年 | 18篇 |
2014年 | 35篇 |
2013年 | 45篇 |
2012年 | 40篇 |
2011年 | 38篇 |
2010年 | 15篇 |
2009年 | 48篇 |
2008年 | 43篇 |
2007年 | 44篇 |
2006年 | 44篇 |
2005年 | 43篇 |
2004年 | 17篇 |
2003年 | 27篇 |
2002年 | 12篇 |
2001年 | 16篇 |
2000年 | 14篇 |
1999年 | 5篇 |
1998年 | 14篇 |
1997年 | 6篇 |
1996年 | 10篇 |
1995年 | 15篇 |
1994年 | 11篇 |
1993年 | 9篇 |
1992年 | 6篇 |
1991年 | 8篇 |
1990年 | 4篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1986年 | 8篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1982年 | 7篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1973年 | 3篇 |
1972年 | 2篇 |
排序方式: 共有728条查询结果,搜索用时 15 毫秒
1.
T. Akatsu T. Murakami K. Ono M. Nishikawa E. Tsuda S.-I. Mochizuki N. Fujise K. Higashio K. Motoyoshi M. Yamamoto N. Nagata 《BONE》1998,23(6):495-498
Osteoclastogenesis inhibitory factor (OCIF) is a novel secreted protein that inhibits osteoclastogenesis both in vitro and in vivo. In this study, we examined the effects of OCIF on serum calcium (Ca) concentrations in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. In normal mice, a single intraperitoneal injection of OCIF reduced serum Ca levels in a dose-dependent manner. Significant decrease in serum Ca (by 1.6 ± 0.3 mg/dL, n = 5) was observed 2 h after the injection of OCIF at 20 mg/kg and the hypocalcemic effect continued for up to 12 h. Serum phosphate (Pi) concentrations also decreased in response to OCIF. Urinary excretion of Ca, Pi, and creatinine did not change significantly after injection of OCIF or vehicle. In hypercalcemic, tumor-bearing nude mice, a single intraperitoneal injection of OCIF at 20 mg/kg resulted in a dramatic decrease in serum Ca (maximal decrease 2.8 ± 0.37 mg/dL, n = 11), which continued for up to 24 h. The results suggest that OCIF decreased serum Ca through its inhibitory effect on bone resorption. Furthermore, it is suggested that OCIF has therapeutic potential for the treatment of hypercalcemic conditions such as malignancy-associated hypercalcemia. 相似文献
2.
3.
Summary It is generally accepted that osteoclasts are responsible for the breakdown and removal of bone matrix constituents. However,
very little is known about the fate of osteocytes during bone resorption. In the present study we have examined sites of bone
destruction in calvaria of young rats aged 4–9 days in the hope of obtaining information on the fate of osteocytes. Decalcified
glutaraldehyde-formaldehyde-fixed specimens were prepared for ultrathin section electron microscopy. When sequentially arranged,
the images obtained suggest that osteoclasts engulf and destroy osteocytes during bone degradation. We propose that the following
sequence of events takes place when a lacuna is opened up by an osteoclast: (1) When the osteoclast comes in contact with
an osteocyte, the villi of the ruffled border become flat and broad. (2) Long osteoclastic extensions surround the osteocyte.
(3) The osteocyte is subsequently internalized with apparent degradation. 相似文献
4.
骨质疏松症(OP)是严重威胁老年人身心健康的常见疾病。随着人口老年化,老年性骨质疏松症发病率逐年增加。近年来内分泌性骨质疏松日见增多,促甲状腺激素(TSH)及促甲状腺激素受体(TSHR)与骨量减少、骨质疏松的关系倍受关注。成骨细胞和破骨细胞上的促甲状腺激素受体的作用是造成这一作用的关键。而此过程还会受到2型碘化甲腺氨酸脱碘酶、肿瘤坏死因子(TNF)等的影响。同时促甲状腺激素受体存在基因多态性,对其功能存在不同程度的影响,也可能是造成骨质疏松的重要原因。通过对这个领域的深入研究为内分泌性骨质疏松的防治提供依据。 相似文献
5.
Background: It is not well known how the immediate precursors of osteoclast develop into osteoclasts in the fetus. This ultrastructural-cytochemical study was designed to clarify the formation process of the osteoclasts and their increased activities in the fetal mouse limb buds after administration of high dose parathyroid hormone (PTH). Methods: Twenty-four or forty-eight hours after the high doses of PTH were injected into amniotic fluid of the pregnant C3H mice, the femoral limb buds of embryos were dissected out. Tartrate-resistant acid phosphatase (TRAP) reactions were performed while preparing specimens for electron microscopy. Results: Both control and PTH-given preosteoclasts and osteoclasts exhibited TRAP-positivities in dense bodies and vesicles. As effects of PTH, a binucleated preosteoclast of tandem fashion was observed. More osteoclastic hyperactivities were observed in the diaphyseal bone marrow. An osteoclast with a large cytoplasm exhibited two sets of clear zones and ruffled borders. Some osteoclasts demonstrated prominent amoeboid figures, while other osteoclasts developed large cytoplasmic vacuoles, which contained pieces of calcified chondroid bars. Conclusions: Our results revealed the progression of maturation from young preosteoclasts to osteoclasts. An existence of a peculiar binucleated preosteoclasts suggested one of the processes for multinucleation of the osteoclast. Quite remarkable osteoclastic hyperactivities were obviously the effects of high dose PTH. Our results also indicated the endophagocytic ability of the osteoclast. How PTH affected the osteoclasts and their precursors in the diaphyseal bone marrow can be speculated. © 1995 Wiley-Liss, Inc. 相似文献
6.
Osteoclasts contain macrophage and megakaryocyte antigens 总被引:6,自引:0,他引:6
N A Athanasou A Heryet J Quinn K C Gatter D Y Mason J O McGee 《The Journal of pathology》1986,150(4):239-246
The origin and mechanism of formation of the osteoclast remains controversial. Although it is known to be derived from a circulating mononuclear percursor, the identity of this cell is unknown. Using a panel of monoclonal antibodies raised against macrophage and other marrow-derived cells, we determined the immunocytochemical staining of human osteoclasts in both fetal bone metaphyseal imprints and frozen sections. Osteoclasts and marrow mononuclear cells were stained by three broad spectrum antimacrophage antibodies, EBM-11, Y182a and BM2. T310, an antibody which stains macrophages and T helper cells, and C17, an antimegakaryocyte antibody, also stained osteoclasts. EBM-11, Y182a and BM2 also stained megakaryocytes in bone imprints as well as normal bone marrow smears. The presence of macrophage-associated antigens in osteoclasts, megakaryocytes and bone marrow mononuclear cells indicates that they are phenotypically similar to macrophages. 相似文献
7.
白细胞介素1刺激破骨细胞性骨吸收作用的实验研究 总被引:3,自引:2,他引:1
目的:了解白细胞介素1β(IL-1β)在破骨细胞性骨吸收中的刺激作用及其相应的作用机制。方法:分别将新生大鼠破骨细胞单独以及和成骨细胞联合接种于预置象牙片的培养板中。24h后培养液中加入不同浓度的IL-1β。继续培养48h,然后取出象牙片,超声处理后行甲苯胺蓝染色,光镜下观察骨吸收陷窝的数目并计算其部面积。结果:IL-1β能够明显增加坡骨细胞和成骨细胞联合培养组象牙片上吸收陷窝的数目和面前,且刺激作用呈剂量依赖性,但对单独培养的破骨细胞无明显刺激作用。结论:IL-1β的刺激骨吸收作用由成骨细胞所介导,而非直接作用于破骨细胞。 相似文献
8.
Etidronate (EHDP) Inhibits Osteoclastic-Bone Resorption, Promotes Apoptosis and Disrupts Actin Rings in Isolate-Mature Osteoclasts 总被引:2,自引:0,他引:2
Hiroi-Furuya E Kameda T Hiura K Mano H Miyazawa K Nakamaru Y Watanabe-Mano M Okuda N Shimada J Yamamoto Y Hakeda Y Kumegawa M 《Calcified tissue international》1999,64(3):219-223
Bisphosphonates, therapeutic reagents against tumoral bone diseases (Paget's disease or osteoporosis), are potent inhibitors
of bone resorption. The mechanisms by which they directly act on mature osteoclasts remain unclear. Using a recently developed
technique for isolation of highly purified mammalian mature osteoclasts, we demonstrated that etidronate [ethane-1-hydroxy-1,1-diphosphonate
(EHDP), 1-hydroxy-1,1-ethylidenebisphosphonate], inhibited directly osteoclastic bone-resorbing activity by pit assay. In
addition, EHDP also directly induced apoptosis and disrupted actin rings in osteoclasts. The data support previous data on
non-purified osteoclasts and results in vivo.
Received: 26 June 1997 / Accepted: 27 July 1998 相似文献
9.
Paolo Bianco Ermanno Bonucci 《Virchows Archiv : an international journal of pathology》1991,419(5):425-431
Summary Alkaline phosphatase (AIP) and tartrate-resistant acid phosphatase (TRAP) activities have been studied comparatively in needle biopsies of the iliac crest of four cases of secondary hyperparathyroidism (renal osteodystrophy). AIP activity was associated with the plasma membrane of osteoblasts and their processes, of reticular cells of bone marrow and of young osteocytes of osteoid borders and woven bone. Moreover, it was detected in the fibroblast-like cells of the endosteal fibrosis. These cells were orderly in arrangement and were parallel to the endosteal surfaces near zones of bone formation. They were disorderly near zones of bone resorption. A strong TRAP-positive reaction was present in osteoclasts and mononuclear cells of endosteal fibrosis and in osteocytes located near active osteoclasts and in woven bone. These results suggest that the socalled fibrosis of hyperparathyroidism, rather than representing reparative, inert tissue, consists of osteoblastlike cells, probably precursors of osteoblasts derived by parathormone-stimulated proliferation of AIP-positive stromal cells of bone marrow, and of TRAP-positive, mononuclear cells, probably preosteoclasts. Moreover, they show that TRAP activity can be present in osteocytes, probably under stimulation by the same factors which stimulate osteoclast activity. The histochemical demonstration of AIP and TRAP facilitates the morphological diagnosis of metabolic bone disease and may improve knowledge of bone physiopathology. 相似文献
10.
目的 探讨骨疏康对1型糖尿病大鼠体外培养的破骨细胞影响。方法 用RANKL和M-CSF诱导1型糖尿病大鼠的股骨骨髓进行体外培养生成类破骨细胞样细胞(OLC)。实验分为正常对照组,1型糖尿病组,正常对照+骨疏康组,1型糖尿病+骨疏康组。骨疏康的浓度为20μg/ml。细胞培养7天后,贴壁细胞固定,抗酒石酸盐酸性磷酸酶染色,破骨细胞计数。结果 1型糖尿病大鼠与正常大鼠组的破骨细胞数比较无明显差别(P>0.05);经骨疏康干预后,1型糖尿病大鼠与正常大鼠的破骨细胞数都明显减少(P<0.01)。结论 1型糖尿病早期破骨细胞形成与正常对照组无明显差异。中药骨疏康明显抑制正常大鼠和1型糖尿病大鼠的破骨细胞形成。 相似文献